EWTX
NASDAQ · Pharmaceuticals
Edgewise Therapeutics Inc
$35.32
-0.26 (-0.73%)
Performance
1D
—
1W
—
1M
—
3M
+16.76%
6M
+93.22%
1Y
+142.25%
YTD
+48.72%
Open$35.35
Previous Close$35.58
Day High$36.21
Day Low$34.67
52W High$39.96
52W Low$12.15
Volume—
Avg Volume1.83M
Market Cap3.82B
P/E Ratio—
EPS$-1.63
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$26.49
Above
SMA 200
$18.41
Above
RSI (14)
53.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+99.4% upside
Current
$35.32
$35.32
Target
$70.44
$70.44
$45.77
$70.44 avg
$86.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 407.17M | 429.50M | 324.39M |
| Net Income | 72.15M | 91.13M | 54.38M |
| Profit Margin | 17.7% | 21.2% | 16.8% |
| EBITDA | 147.48M | 172.82M | 113.17M |
| Free Cash Flow | 69.60M | 65.40M | 42.96M |
| Rev Growth | +16.1% | +0.2% | +22.1% |
| Debt/Equity | 0.29 | 0.25 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |